← All tickers

Is IVVD Worth Buying in 2026?

Invivyd, Inc. Common Stock

STOCK BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Updated 2026-06-07

Here’s whether Invivyd, Inc. Common Stock (IVVD) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: strong 1-year return of +11.3%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-6.06% over 10 days); 3-month momentum negative (-45.5%). Currently 66.5% off its 52-week high. Score: -4/7.

Ready to act on this? 📈 Trade on Webull

IVVD is trading below its 200-day MA ($1.70) — a key warning sign the longer-term trend is under pressure. An RSI of 34.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +11.3% compares to +24.4% for SPY (trailed the market by 13.0%). The current 66.5% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $11,134 today
vs. S&P 500 (SPY) — same period trailed market by 13.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✗Above 200-day MA ($1.70)
✗Above 50-day MA ($1.37)
✓RSI(14) neutral zone (30–70) — currently 34.5
✓Positive return (+11.3%)
!Within 10% of period high (−66.5%)
Period Range $1.03
$0.48 $3.07
RSI (14) 34.5
0 · OversoldOverbought · 100

Key Metrics

Price$1.03
Period Return+11.3%
Period High$3.07
Period Low$0.48
Drawdown−66.5%
MA-50$1.37
MA-200$1.70
RSI (14)34.5
Avg Volume (30d)2.8M
vs. SPYtrailed by 13.0%
Return Rank#611 of 1245

Trade IVVD

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers